We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.88%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$6.63B
AUM Growth
+$133M
(+2.1%)
Cap. Flow
+$377M
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
12.08%
Holding
5,964
New
870
Increased
1,645
Reduced
2,091
Closed
1,097
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.5M |
| 2 |
WLL
Whiting Petroleum Corporation
WLL
|
+$10.4M |
| 3 |
JCP
J.C. Penney Company, Inc.
JCP
|
+$8.32M |
| 4 |
Gilead Sciences
GILD
|
+$7.66M |
| 5 |
United States Oil Fund
USO
|
+$5.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herc Holdings
HRI
|
+$22.1M |
| 2 |
Kinder Morgan
KMI
|
+$16.3M |
| 3 |
AstraZeneca
AZN
|
+$11.7M |
| 4 |
TIBX
TIBCO SOFTWARE INC
TIBX
|
+$9.91M |
| 5 |
PAY
Verifone Systems Inc
PAY
|
+$9.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.66% |
| 2 | Industrials | 2.15% |
| 3 | Technology | 2.02% |
| 4 | Energy | 1.33% |
| 5 | Consumer Discretionary | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPN
426
CALL
DELISTED
Calpine Corporation
CPN
| $2.99M | 0.05% |
135,000
+71,600
| +113% | +$1.59M |
|
427
CALL
Edwards Lifesciences
EW
$51.6B
| $2.98M | 0.05% |
140,400
+34,800
| +33% | +$699K |
|
428
PUT
Tapestry
TPR
$31.5B
| $2.97M | 0.04% |
79,000
+8,800
| +13% | +$310K |
|
|
HZNP
429
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.95M | 0.04% |
228,600
-58,800
| -20% | -$736K |
|
|
GDP
430
CALL
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
| $2.95M | 0.04% |
663,500
+438,900
| +195% | +$3.42M |
|
431
PUT
Sysco
SYY
$39.6B
| $2.94M | 0.04% |
74,200
-3,800
| -5% | -$147K |
|
432
PUT
MGIC Investment
MTG
$6.35B
| $2.94M | 0.04% |
315,400
-90,700
| -22% | -$796K |
|
433
PUT
Vanda Pharmaceuticals
VNDA
$321M
| $2.93M | 0.04% |
204,800
+162,200
| +381% | +$1.92M |
|
434
Avis
CAR
$4.98B
| $2.93M | 0.04% |
+44,184
| New | +$2.53M |
|
|
NSR
435
PUT
DELISTED
Neustar Inc
NSR
| $2.92M | 0.04% |
105,100
-29,100
| -22% | -$764K |
|
|
ESV
436
PUT
DELISTED
Ensco Rowan plc
ESV
| $2.91M | 0.04% |
24,275
+17,825
| +276% | +$2.56M |
|
437
CALL
Genworth Financial
GNW
$3.75B
| $2.9M | 0.04% |
341,800
+67,200
| +24% | +$706K |
|
|
PCYC
438
DELISTED
PHARMACYCLICS INC
PCYC
| $2.89M | 0.04% |
23,663
+6,686
| +39% | +$854K |
|
|
BBEP
439
PUT
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
| $2.89M | 0.04% |
412,900
+271,300
| +192% | +$3.72M |
|
440
CALL
Western Union
WU
$2.26B
| $2.89M | 0.04% |
161,200
+54,300
| +51% | +$942K |
|
441
PUT
Neurocrine Biosciences
NBIX
$16.9B
| $2.88M | 0.04% |
128,900
+67,400
| +110% | +$1.28M |
|
442
Liberty Global Class A
LBTYA
$3.73B
| $2.87M | 0.04% |
69,215
+15,283
| +28% | +$586K |
|
443
PUT
Halozyme
HALO
$9.84B
| $2.85M | 0.04% |
294,900
+160,000
| +119% | +$1.42M |
|
444
Blackstone
BX
$110B
| $2.83M | 0.04% |
85,238
-35,730
| -30% | -$1.12M |
|
|
SE
445
CALL
DELISTED
Spectra Energy Corp Wi
SE
| $2.83M | 0.04% |
77,900
-6,000
| -7% | -$226K |
|
446
Green Plains
GPRE
$1.19B
| $2.83M | 0.04% |
114,011
+45,615
| +67% | +$1.37M |
|
|
MLNX
447
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $2.81M | 0.04% |
65,700
+4,900
| +8% | +$213K |
|
448
CALL
Alnylam Pharmaceuticals
ALNY
$29.3B
| $2.8M | 0.04% |
28,900
+9,000
| +45% | +$834K |
|
|
449
PUT
Alnylam Pharmaceuticals
ALNY
$29.3B
| $2.8M | 0.04% |
28,900
+24,700
| +588% | +$2.29M |
|
|
AEGR
450
PUT
DELISTED
Aegerion Pharmaceuticals
AEGR
| $2.79M | 0.04% |
133,300
-26,200
| -16% | -$660K |
|
Similar funds
SCP
Group One Trading's Q4 2014 Portfolio in Review
As of Q4 2014, Group One Trading held 5,964 positions worth $6.63B, up 2.1% from $6.49B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Group One Trading deployed $377M of net new capital in Q4 2014, opening 870 new positions and adding to 1,645 existing holdings. Its largest new stake was Whiting Petroleum Corporation: 684 shares worth $6.77M.
By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, down from 2.8% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was AstraZeneca, an estimated $11.7M trimmed.
- Group One Trading's largest Q4 2014 buy was Whiting Petroleum Corporation: 684 shares worth $6.77M.
- Group One Trading added most to Allergan plc in Q4 2014, an estimated $18.5M increase.
- Group One Trading's biggest Q4 2014 reduction was AstraZeneca, cutting an estimated $11.7M.
- Group One Trading fully exited Herc Holdings in Q4 2014, selling an estimated $22.1M.
- Group One Trading's ten largest holdings make up 12% of its $6.63B portfolio in Q4 2014.
- Group One Trading opened 870 new positions and closed 1,097 in Q4 2014.
- Group One Trading's portfolio value rose 2.1% quarter-over-quarter to $6.63B.
Based on Group One Trading's 13F filing for Q4 2014, filed 11 Feb 2015.